Roivant
2 articles · Feb 2026
Summary being generated — check back shortly.
Coverage Timeline 2 articles
Feb 6 2026
healthline
Biotech News Roundup: TrumpRx Launches, Roivant's Breakthrough, and More
In a week filled with significant developments in the biotech industry, President Trump launched TrumpRx, a platform aimed at lowering drug prices, while Roivant's immune drug showed promising results in treating a rare skin disease. Meanwhile, the industry saw a flurry of comings and goings, IPOs, and advancements in gene therapy.
Feb 6 2026
healthline
Biotech and Pharma News Roundup: TrumpRx Launches, Roivant's Breakthrough, and More
This week in biotech and pharma news, President Trump launched TrumpRx, a website aimed at lowering drug prices, while Roivant's immune drug showed promising results in treating a rare skin disease. Meanwhile, the industry saw a flurry of comings and goings, and companies faced challenges with IPOs and gene therapy.